FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

Date:

The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry…

Share post:

Subscribe

Popular

More like this
Related

Biden confronts 2024 weak spots with young, Black voters at Morehouse commencement

President Joe Biden's Black voter support has fallen since...

How to own Big Tech and stay diversified, plus learning more about stock buybacks

Yes, it's possible to have a diversified portfolio with...

From $35,000 to $446,000: What it cost to renovate a $1 home in Italy

Buying a home in the Italian countryside for cheap...